News
The first gene-editing treatment: 10 Breakthrough Technologies 2024 Sickle-cell disease is the first illness to be beaten by CRISPR, but the new treatment comes with an expected price tag of $2 to ...
Ichor has also granted an option for RheoGene to license Ichor’s TriGrid™ Delivery System to develop proprietary therapeutics. RheoGene claims that’s RheoSwitch ® Therapeutic System (RTS) is a safe ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback